Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

Published:2012-06 Issue:9833 Volume:379 Page:2270-2278
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gallwitz Baptist,Guzman Juan,Dotta Francesco,Guerci Bruno,Simó Rafael,Basson Bruce R,Festa Andreas,Kiljański Jacek,Sapin Hélène,Trautmann Michael,Schernthaner Guntram

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

2. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

3. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy;Kahn;N Engl J Med,2006

4. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits;Drucker;Diabetes Care,2010

5. Management of type 2 diabetes: new and future developments in treatment;Tahrani;Lancet,2011

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians;Annals of Internal Medicine;2024-05

2. Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review;Diabetologia;2024-01-04

3. Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications;Therapeutic Advances in Endocrinology and Metabolism;2024-01

4. The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials;Diabetology & Metabolic Syndrome;2023-07-26

5. Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs;BMC Endocrine Disorders;2022-10-19